Product Code: NBT FDA class 2 21 CFR 866.5785

Antibodies, Saccharomyces Cerevisiae (S.Cerevisiae)

Immunology

The Saccharomyces Cerevisiae Antibody Test (ASCA) is an in vitro diagnostic immunology device used to detect anti-Saccharomyces cerevisiae antibodies (ASCA) in patient serum, which are a marker associated with Crohn's disease and are used to help differentiate Crohn's disease from ulcerative colitis in inflammatory bowel disease diagnostics. Classified as FDA Class 2, it requires 510(k) premarket clearance under regulation 866.5785 (Immunology specialty). This device is eligible for third-party 510(k) review.

510(k)s
8
FEI Numbers
5
Registration Numbers
5
Unique Applicants
6
Years Active
7

Research product code NBT in seconds

The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.

Free to try · every answer cites its records

Basic Information

Product Code
NBT
Device Class
FDA class 2
Regulation Number
866.5785
Medical Specialty
Immunology
Review Panel
IM
Submission Type
1

Device Characteristics

GMP Exempt
Implant
Life Sustain/Support
Third Party
Summary Malfunction Reporting

510(k) Clearance History

Loading...

Related 510(k) Clearances

This FDA classification is associated with 8 510(k) clearances via K numbers.

K Number Device Name
K071711 ASCA-CHEK
K051927 TECHLAB ASCA-CHEK
K051492 AESKULISA ASCA A
K042579 BINDAZYME HUMAN ASCA IGG AND IGA EIA DIAGNOSTIC TEST KIT
K032860 IMMULISA ANTI-SACCHAROMYCES CEREVISIAE ANTIBODY (ASCA) (IGA)
K032850 IMMULISA ANTI-SACCHAROMYCES CEREVISIAE ANTIBODY (ASCA) (IGG)
K000733 QUANTA LITE ASCA (S. CEREVISIAE) IGA ELISA
DEN000007 QUANTA LITE ASCA (S. CEREVISIAE) IGG ELISA

FEI Numbers

This FDA classification entry is associated with 5 FEI numbers. Click on an entry to view related FDA registrations.

Registration Numbers

This FDA classification entry is associated with 5 registration numbers. Click on an entry to view related FDA registrations.